Olema Oncology
Edit

Olema Oncology

https://olema.com/
Last activity: 11.03.2024
Categories: LivingInformationHumanHealthTechGrowthDrugDevelopmentDesignCareBioTech
At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Followers
189
Mentions
11
Location: United States, California, San Francisco
Total raised: $139M
Founded date: 2007

Investors 2

Funding Rounds 2

DateSeriesAmountInvestors
01.10.2020Series C$85M-
22.07.2020Series B$54M-

Mentions in press and media 11

DateTitleDescriptionSource
11.03.2024Olema Oncology Reports Fourth Quarter and Full-Year 2023 Fin...-globenewsw...
06.03.2024Olema Oncology Announces Publication of Data Highlighting Pa...-globenewsw...
04.03.2024Olema Oncology Reports Inducement Grants Under Nasdaq Listin...SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Onc...einpresswi...
01.10.2020Olema Oncology Raises $85M in Series C FinancingOlema Oncology, a San Francisco, CA-based clinical-stage biopharmaceutical company focused on the di...finsmes.co...
24.07.2020Olema Oncology Scores $54M in Series B SAN FRANCISCO, CA, Olema Oncology announced the closing of an oversubscribed $54 million Series B ...vcnewsdail...
23.07.2020Olema Oncology Secures $54 Million To Advance Lead Program I...Olema Oncology — a biopharmaceutical company that is developing innovative targeted therapies for wo...pulse2.com...
22.07.2020Olema Oncology grabs $54M for breast cancer programOlema Oncology, a biotech focused on women’s cancers, raised $54 million to push its lead program in...fiercebiot...
22.07.2020Olema Oncology Raises $54M in Series B FinancingOlema Oncology, a San Francisco, CA-based biopharmaceutical company developing innovative targeted t...finsmes.co...
22.07.2020Olema Oncology grabs $54M for breast cancer programOlema Oncology, a biotech focused on women’s cancers, raised $54 million to push its lead program in...fiercebiot...
-Developing a next generation endocrine therapy for ER+/HER2-...Not all SERDs are created equal Our evolving understanding of the underlying biology of breast cance...statnews.c...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In